泰凌醫藥：2019中期報告.pdf

1、Interim Report 2019 中期報告 Interim Report 2019 中期報告(Incorporated in the Cayman Islands with limited liability)(於開曼群島註冊成立之有限公司)CONTENTS 目 錄Board of Directors and Board Committees董事會及董事委員會Corporate Information公司資料Financial Highlights財務摘要Management Discussion and Analysis管理層討論及分析Other Information其他資料Cond

2、ensed Consolidated Income Statement簡明綜合收益表Condensed Consolidated Statement of Comprehensive Income簡明綜合全面收益表Condensed Consolidated Statement of Financial Position簡明綜合財務狀況表Condensed Consolidated Statement of Changes in Equity簡明綜合權益變動表Condensed Consolidated Statement of Cash Flow簡明綜合現金流量表Notes to the C

3、ondensed Consolidated Interim Financial Statements簡明綜合中期財務報表附註2356263840414344452China NT Pharma Group Company Limited Interim Report 2019Board of Directors and Board Committees董事會及董事委員會BOARD OF DIRECTORS董事會Executive DirectorsMr.NG Tit(Chairman and Chief Executive Officer)執行董事 吳鐵先生（主席兼行政總裁）Ms.CHIN Y

4、u錢余女士Mr.WU Weizhong吳為忠先生Mr.WANG Fei(appointed on 10 January 2019)王飛先生（於2019年1月10日獲委任）Non-executive DirectorsDr.QIAN Wei非執行董事錢唯博士Ms.LOU Jianying婁健穎女士Independent Non-executive DirectorsMr.Patrick SUN獨立非執行董事辛定華先生Mr.YU Tze Shan Hailson余梓山先生Dr.YAN Hong嚴弘博士BOARD COMMITTEES董事委員會Audit CommitteeMr.Patrick SU

5、N(Chairman)審核委員會辛定華先生（主席）Mr.YU Tze Shan Hailson余梓山先生Dr.YAN Hong嚴弘博士Remuneration CommitteeMr.YU Tze Shan Hailson(Chairman)薪酬委員會余梓山先生（主席）Mr.Patrick SUN辛定華先生Mr.NG Tit吳鐵先生Nomination CommitteeMr.NG Tit(Chairman)提名委員會吳鐵先生（主席）Mr.Patrick SUN辛定華先生Mr.YU Tze Shan Hailson余梓山先生3中國泰凌醫藥集團有限公司 中期報告 2019Corporate In

6、formation公司資料COMPANY SECRETARYMs.LAI Siu KuenAUDITORSCrowe Horwath(HK)CPA LimitedCertified Public AccountantsLEGAL ADVISORS AS TO HONG KONG LAWSKing&Wood MallesonsPRINCIPAL PLACE OF BUSINESS IN HONG KONG28th Floor,The Wellington198 Wellington StreetSheung WanHong KongPRINCIPAL PLACE OF BUSINESS AND